Augmedics announced that it appointed Rick Anderson as executive chairman of its board and Bradley Paddock as the board’s independent director.
Chicago-based Augmedics said yesterday in a news release that Anderson joined the board in March upon the closing of Augmedics’ oversubscribed $36 million Series C financing round. Paddock then joined in May and both will assume their new roles effective immediately.
Anderson spent more than three decades as an executive, investor and board member for emerging growth and market-leading healthcare companies. He also serves as the chairman of Revival Healthcare Capital, having previously served as chairman & CEO of ConvaTec, as well as company group chairman at Johnson & Johnson.
Paddock holds over 25 years of experience in medical devices and currently serves as president & CEO at CeQur. Other executive roles for Paddock include global president of spine at Stryker, VP of global sales & marketing at Bausch + Lomb and VP of sales at Kyphon.
The two now join the leadership team of Augmedics, which develops the Xvision Spine, which it touts as the first AR guidance system to be used in surgery. The system is designed to allow surgeons to visualize the 3D spinal anatomy during surgery as if it were “X-ray vision.”
“Rick and Brad have provided invaluable guidance from the start,” Augmedics CEO & founder Nissan Elimelech said in the release. “We are delighted to have the leadership of these two renowned industry veterans as we continue to bring xvision to surgeons across the U.S. and revolutionize the way spine surgery is done.”